Associated Papers
Spectrum of Beta-Thalassemia Mutations in Potential Carriers with Microcytic Hypochromic Anemia from Mazandaran and Golestan, Northern Provinces of Iran.
Mousavi SS et al.
Biomed Research International, 2024
Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.
Tamana S et al.
Elife, 2022
36453528 (PubMed )
Supplement: elife-79713-supp2.xlsx › Input-Full_dataset
Autoimmune hepatitis in genetic syndromes: A literature review.
Capra AP et al.
World Journal of Hepatology, 2021
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements.
Patsali P et al.
Journal of Clinical Medicine, 2019
31766235 (PubMed )
Supplement: jcm-08-01959-s001.pdf
A Novel β-Thalassemia Mutation in a Chinese family: IVS-II-203-205 (TCT>CC) (HBB: c.315+203TCT>CC).
Chen JK et al.
Hemoglobin, 2018
The molecular basis of β-thalassemia.
Thein SL
Cold Spring Harbor Perspectives in Medicine, 2013
Molecular basis and prenatal diagnosis of β-thalassemia among Balouch population in Iran.
Miri-Moghaddam E et al.
Prenatal Diagnosis, 2011
Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in Khuzestan province of Iran.
Fakher R et al.
Indian Journal of Human Genetics, 2007
Splice junction [IVS-II-1 (G-->C)] thalassemia; a new mutation detected in an Iranian patient.
Nozari G et al.
Hemoglobin, 1993
Select a paper to view details